DrugPatentWatch Database Preview
Drugs in Development Information for Ibodutant
Summary for Ibodutant
| US Patents | 3 |
| International Patents | 105 |
| US Patent Applications | 4 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2014-03-01) |
| Vendors | 6 |
US Patents for Ibodutant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ibodutant | ➤ Sign Up | Linear basic compounds having NK-2 antagonist activity and formulations thereof | Menarini Ricerche S.P.A. (Pomezia, IT) | ➤ Sign Up |
| Ibodutant | ➤ Sign Up | Pharmaceutical compositions based on NK2 antagonists for pediatric use | Laboratori Guidotti S.p.A. (Pisa, IT) | ➤ Sign Up |
| Ibodutant | ➤ Sign Up | Process for the preparation of ibodutant (MEN15596) and related intermediates | Malesci Istituto Farmacobiologico S.p.A. (Bagno A Ripoli, IT) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Ibodutant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ibodutant | Argentina | 037044 | 2021-10-29 | ➤ Sign Up |
| Ibodutant | Austria | 339439 | 2021-10-29 | ➤ Sign Up |
| Ibodutant | Australia | 2002351794 | 2021-10-29 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
